SANTA CLARA, Calif.,
Nov. 7, 2018 /PRNewswire/
-- SI-BONE, Inc. (Nasdaq: SIBN), a medical device company
that is pioneering the minimally invasive surgical treatment of the
sacroiliac joint with the iFuse Implant System®, today announced it
will report financial results for the third quarter of 2018 after
market close on Thursday, November 29,
2018. Company management will host a corresponding
conference call beginning at 1:30 p.m.
Pacific Time (4:30 p.m. Eastern
Time) on Thursday, November 29,
2018.
Investors interested in listening to the conference call may do
so by dialing (866) 470-1968 for U.S. callers or (409) 217-8248 for
international callers (Conference ID: 1083139). The webcast can be
accessed at http://investor.SI-BONE.com.
Within 24 hours of the webcast, a replay will be available by
clicking on the Events link at http://investor.SI-BONE.com.
About SI-BONE, Inc.
SI-BONE is a medical device company that pioneered the iFuse
Implant System, a minimally invasive surgical system for fusion of
the sacroiliac joint to treat sacroiliac joint dysfunction.
The SI joint is believed to be the last major joint with a
clinically proven surgical treatment. The iFuse Implant,
commercially available since 2009, is believed to be the only
SI joint fusion device supported by multiple prospective clinical
studies showing improved pain, patient function and quality of life
resulting from treatment. There are over 60 peer-reviewed
publications supporting the safety, effectiveness, and
biomechanical and economic benefits unique to the iFuse
Implant. This body of evidence has enabled multiple
government and private payors to establish coverage of the SI joint
fusion procedure exclusively when performed with the iFuse Implant
System.
![SI-BONE iFuse Logo. (PRNewsFoto/SI-BONE, Inc.) SI-BONE iFuse Logo. (PRNewsFoto/SI-BONE, Inc.)](https://mma.prnewswire.com/media/141213/si_bone__inc__ifuse_logo.jpg)
View original content to download
multimedia:http://www.prnewswire.com/news-releases/si-bone-to-report-third-quarter-financial-results-on-november-29-2018-300745881.html
SOURCE SI-BONE, Inc.